TOKYO, March 30, 2012 - GlaxoSmithKline K.K. (President: Philippe Fauchet, Head Office: Shibuya-ku, Tokyo, hereinafter referred to as GSK) and Dainippon Sumitomo ...

Mylan has launched generic versions of GlaxoSmithKline’s Paxil CR (paroxetine hydrochloride controlled-release tablets) in 12.5mg and 25mg dosage strengths. Mylan has also received the right to market ...

July 13, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for paroxetine hydrochloride extended release tablets, 12.5 mg and 25 mg, for the treatment of ...

GlaxoSmithKline has returned its antidepressant Paxil CR to the market, nearly four months after federal officials seized the drug from three factories for failing to meet manufacturing standards. The ...

U.S. officials Friday seized batches of GlaxoSmithKline's diabetes drug Avandamet and controlled-release antidepressant Paxil CR because of concerns over manufacturing quality. The U.S. Food and Drug ...

WASHINGTON — The Food and Drug Administration halted distribution Friday of the popular antidepressant Paxil CR and the diabetes drug Avandamet, citing concerns about manufacturing problems. FDA ...

Federal officials seized two types of drugs Friday from a Knoxville, Tenn., distribution center of GlaxoSmithKline PLC after the Food and Drug Administration found the drug company failed to meet ...

Officials in the U.S. seized batches of a diabetes drug and an antidepressant medication on Friday because of concerns the drug company didn't meet manufacturing standards. The drugs are Paxil CR, a ...

On March 4, US marshals seized stocks of "Avandamet" (rosiglitazonemaleate/metformin hydrochloride, for type 2 diabetes) and "Paxil CR"(paroxetine hydrochloride controlled release, for depression ...

May 12, 2006 — The US Food and Drug Administration (FDA) and GlaxoSmithKline have warned healthcare professionals regarding the potential increased risk for suicidal behavior associated with use of ...

The Bank of Japan concludes its first policy meeting of the year on Friday with the outcome to be announced days after the inauguration of U.S. President Donald Trump. category Taiwan's HTC to sell ...

PITTSBURGH, Oct. 23 -- Mylan Inc. today announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into a patent license and settlement agreement with GlaxoSmithKline (GSK) relating ...